Showing results (21-30 of 251) with videos related to
Sort By:
Pageof 26
Anticancer Research|September 10, 2014
Phase I study of Efatutazone, an oral PPARγ agonist, in patients with metastatic solid tumorsHaruyasu Murakami, Akira Ono, Toshiaki Takahashi, et al.Annals of Nuclear Medicine|September 9, 2010
Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancerKyoichi Kaira, Masahiro Endo, Koiku Asakura, et al.Japanese Journal of Clinical Oncology|May 20, 2020
A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study)Shogo Nomura, Yasushi Goto, Tomonori Mizutani, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Evaluation of the recommended dose and efficacy of amrubicin as second- and third-line chemotherapy for small cell lung cancerSatoshi Igawa, Nobuyuki Yamamoto, Shinya Ueda, et al.Japanese Journal of Radiology|November 30, 2010
Intestinal metastasis from non-small-cell lung cancer initially detected by ¹⁸F-fluorodeoxyglucose positron emission tomographyHiroaki Akamatsu, Asuka Tsuya, Kyoichi Kaira, et al.Molecular and Clinical Oncology|December 1, 2016
Doublet chemotherapy with cisplatin and pemetrexed is associated with a favorable outcome in patients with advanced non-squamous non-small-cell lung cancer who are eligible for bevacizumab and maintenance therapyKazuhisa Nakashima, Haruyasu Murakami, Shota Omori, et al.Asia-Pacific Journal of Oncology Nursing|September 6, 2022
Exploring the educational needs for severe immune-related adverse events of PD-1/PD-L1 inhibitors in advanced lung cancer: A single-center observational studySakiko Aso, Nao Kawamura, Hideki Yanagida, et al.Investigational New Drugs|May 4, 2011
Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancerIsamu Okamoto, Nobuyuki Yamamoto, Kaoru Kubota, et al.International Journal of Clinical Oncology|December 8, 2009
Thymic squamous cell carcinoma producing granulocyte colony-stimulating factor associated with a high serum level of interleukin 6Eriko Ayabe, Kyoichi Kaira, Toshiaki Takahashi, et al.BMC Pulmonary Medicine|December 29, 2022
Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasisMichihito Miyagi, Hirohisa Katagiri, Hideki Murata, et al.Pageof 26